NM_015910.7:c.176T>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015910.7(WDPCP):​c.176T>A​(p.Ile59Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00218 in 1,596,126 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 9 hom. )

Consequence

WDPCP
NM_015910.7 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:6

Conservation

PhyloP100: 3.64

Publications

4 publications found
Variant links:
Genes affected
WDPCP (HGNC:28027): (WD repeat containing planar cell polarity effector) This gene encodes a cytoplasmic WD40 repeat protein. A similar gene in frogs encodes a planar cell polarity protein that plays a critical role in collective cell movement and ciliogenesis by mediating septin localization. Mutations in this gene are associated with Bardet-Biedl syndrome 15 and may also play a role in Meckel-Gruber syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
WDPCP Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 15
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • heart defect - tongue hamartoma - polysyndactyly syndrome
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019254684).
BP6
Variant 2-63487479-A-T is Benign according to our data. Variant chr2-63487479-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 220911.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00152 (232/152132) while in subpopulation NFE AF = 0.00278 (189/67964). AF 95% confidence interval is 0.00246. There are 2 homozygotes in GnomAd4. There are 102 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDPCPNM_015910.7 linkc.176T>A p.Ile59Asn missense_variant Exon 3 of 18 ENST00000272321.12 NP_056994.3 O95876-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDPCPENST00000272321.12 linkc.176T>A p.Ile59Asn missense_variant Exon 3 of 18 1 NM_015910.7 ENSP00000272321.7 O95876-1

Frequencies

GnomAD3 genomes
AF:
0.00153
AC:
232
AN:
152014
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000604
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000788
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00278
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00136
AC:
338
AN:
248120
AF XY:
0.00131
show subpopulations
Gnomad AFR exome
AF:
0.000521
Gnomad AMR exome
AF:
0.000760
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000140
Gnomad NFE exome
AF:
0.00258
Gnomad OTH exome
AF:
0.00117
GnomAD4 exome
AF:
0.00224
AC:
3240
AN:
1443994
Hom.:
9
Cov.:
27
AF XY:
0.00217
AC XY:
1559
AN XY:
719468
show subpopulations
African (AFR)
AF:
0.000424
AC:
14
AN:
33010
American (AMR)
AF:
0.000787
AC:
35
AN:
44484
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25914
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39486
South Asian (SAS)
AF:
0.000245
AC:
21
AN:
85748
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5504
European-Non Finnish (NFE)
AF:
0.00280
AC:
3068
AN:
1096924
Other (OTH)
AF:
0.00158
AC:
94
AN:
59638
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.422
Heterozygous variant carriers
0
130
260
389
519
649
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
232
AN:
152132
Hom.:
2
Cov.:
32
AF XY:
0.00137
AC XY:
102
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41526
American (AMR)
AF:
0.000786
AC:
12
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00278
AC:
189
AN:
67964
Other (OTH)
AF:
0.00190
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00208
Hom.:
0
Bravo
AF:
0.00160
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000279
AC:
1
ESP6500EA
AF:
0.00247
AC:
20
ExAC
AF:
0.00110
AC:
133
EpiCase
AF:
0.00263
EpiControl
AF:
0.00220

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:4
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WDPCP: BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 09, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 22, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 15 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Heart defect - tongue hamartoma - polysyndactyly syndrome;C3150127:Bardet-Biedl syndrome 15 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

WDPCP-related disorder Benign:1
Sep 15, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Benign
0.0070
T;.;.
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.10
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.019
T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
1.7
L;L;.
PhyloP100
3.6
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.0
N;N;D
REVEL
Benign
0.25
Sift
Uncertain
0.022
D;D;D
Sift4G
Uncertain
0.0060
D;D;.
Polyphen
0.63
P;P;.
Vest4
0.86
MVP
0.78
MPC
0.37
ClinPred
0.031
T
GERP RS
3.1
Varity_R
0.33
gMVP
0.39
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202196322; hg19: chr2-63714613; API